Insider Trading disclosures for Tarsus Pharmaceuticals Inc

The latest disclosure was made by Jeffrey S. Farrow in Tarsus Pharmaceuticals Inc where a trade of 1,284 Common Stock done at an average price of $46.3 was reported to US exchanges on March 18, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Jeffrey S. Farrow	See Remarks	Sale of securities on an exchange or to another person at price $ 46.29 per share.	18 Mar 2025	1,284	24,871	-	46.3	59,436	Common Stock
Jeffrey S. Farrow	See Remarks	Sale of securities on an exchange or to another person at price $ 50.11 per share.	18 Mar 2025	1,186	22,431	-	50.1	59,430	Common Stock
Jeffrey S. Farrow	See Remarks	Sale of securities on an exchange or to another person at price $ 47.40 per share.	18 Mar 2025	1,254	23,617	-	47.4	59,440	Common Stock
Aziz Mottiwala	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 50.11 per share.	18 Mar 2025	3,365	65,057	-	50.1	168,620	Common Stock
Aziz Mottiwala	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 47.40 per share.	18 Mar 2025	3,557	68,422	-	47.4	168,602	Common Stock
Aziz Mottiwala	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 46.29 per share.	18 Mar 2025	3,643	71,979	-	46.3	168,634	Common Stock
Bobak Azamian	Director, President/CEO and Board Chair	Sale of securities on an exchange or to another person at price $ 46.29 per share.	18 Mar 2025	7,131	70,720	-	46.3	330,094	Common Stock
Bobak Azamian	Director, President/CEO and Board Chair	Sale of securities on an exchange or to another person at price $ 47.40 per share.	18 Mar 2025	8,551	62,169	-	47.4	405,317	Common Stock
Bobak Azamian	Director, President/CEO and Board Chair	Sale of securities on an exchange or to another person at price $ 50.11 per share.	18 Mar 2025	8,534	53,635	-	50.1	427,639	Common Stock
Seshadri Neervannan	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 46.29 per share.	18 Mar 2025	2,605	84,660	-	46.3	120,585	Common Stock
Seshadri Neervannan	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 50.11 per share.	18 Mar 2025	2,435	79,682	-	50.1	122,018	Common Stock
Seshadri Neervannan	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 47.40 per share.	18 Mar 2025	2,543	82,117	-	47.4	120,538	Common Stock
Dianne C. Whitfield	Chief Human Resources Officer	Sale of securities on an exchange or to another person at price $ 47.40 per share.	18 Mar 2025	2,259	48,492	-	47.4	107,077	Common Stock
Dianne C. Whitfield	Chief Human Resources Officer	Sale of securities on an exchange or to another person at price $ 50.11 per share.	18 Mar 2025	2,137	46,355	-	50.1	107,085	Common Stock
Dianne C. Whitfield	Chief Human Resources Officer	Sale of securities on an exchange or to another person at price $ 46.29 per share.	18 Mar 2025	2,315	50,751	-	46.3	107,161	Common Stock
Bryan Wahl	General Counsel	Sale of securities on an exchange or to another person at price $ 50.11 per share.	18 Mar 2025	3,084	51,712	-	50.1	154,539	Common Stock
Bryan Wahl	General Counsel	Sale of securities on an exchange or to another person at price $ 46.29 per share.	18 Mar 2025	3,341	58,057	-	46.3	154,655	Common Stock
Bryan Wahl	General Counsel	Sale of securities on an exchange or to another person at price $ 47.40 per share.	18 Mar 2025	3,261	54,796	-	47.4	154,571	Common Stock
Jeffrey S. Farrow	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	8,019	24,060	-		-	Restricted Stock Units
Jeffrey S. Farrow	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	8,019	26,155	-		-	Common Stock
Aziz Mottiwala	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	20,957	75,622	-		-	Common Stock
Aziz Mottiwala	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	8,019	24,060	-		-	Restricted Stock Units
Aziz Mottiwala	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	8,148	16,296	-		-	Restricted Stock Units
Aziz Mottiwala	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	4,790	4,790	-		-	Restricted Stock Units
Bobak Azamian	Director, President/CEO and Board Chair	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	51,395	77,851	-		-	Common Stock
Bobak Azamian	Director, President/CEO and Board Chair	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	23,121	69,364	-		-	Restricted Stock Units
Bobak Azamian	Director, President/CEO and Board Chair	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	16,975	33,950	-		-	Restricted Stock Units
Bobak Azamian	Director, President/CEO and Board Chair	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	11,299	11,300	-		-	Restricted Stock Units
Seshadri Neervannan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	8,148	16,296	-		-	Restricted Stock Units
Seshadri Neervannan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	5,097	5,097	-		-	Restricted Stock Units
Seshadri Neervannan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	21,264	87,265	-		-	Common Stock
Seshadri Neervannan	Chief Operating Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	8,019	24,060	-		-	Restricted Stock Units
Dianne C. Whitfield	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	7,175	21,527	-		-	Restricted Stock Units
Dianne C. Whitfield	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	18,885	53,066	-		-	Common Stock
Dianne C. Whitfield	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	4,462	4,463	-		-	Restricted Stock Units
Dianne C. Whitfield	Chief Human Resources Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	7,248	14,497	-		-	Restricted Stock Units
Bryan Wahl	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	19,213	61,398	-		-	Common Stock
Bryan Wahl	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	4,790	4,790	-		-	Restricted Stock Units
Bryan Wahl	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	7,248	14,497	-		-	Restricted Stock Units
Bryan Wahl	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2025	7,175	21,527	-		-	Restricted Stock Units
Andrew Goldberg	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Mar 2025	7,000	0	-		-	Stock Option (right to buy)
Andrew Goldberg	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.89 per share.	07 Mar 2025	7,000	13,350	-	12.9	90,230	Common Stock
Jeffrey S. Farrow	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2025	30,628	30,628	-		-	Stock Option (right to buy)
Jeffrey S. Farrow	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2025	20,089	20,089	-		-	Restricted Stock Units
Aziz Mottiwala	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2025	22,098	22,098	-		-	Restricted Stock Units
Aziz Mottiwala	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2025	33,691	33,691	-		-	Stock Option (right to buy)
Bobak Azamian	Director, President/CEO and Board Chair	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2025	90,736	90,736	-		-	Stock Option (right to buy)
Bobak Azamian	Director, President/CEO and Board Chair	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2025	59,512	59,512	-		-	Restricted Stock Units
Seshadri Neervannan	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2025	30,628	30,628	-		-	Stock Option (right to buy)
Seshadri Neervannan	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2025	20,089	20,089	-		-	Restricted Stock Units

Showing 1 to 50 of 430 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

158.57% Gain from 52W Low

Insider Trading disclosures for Tarsus Pharmaceuticals Inc

The latest disclosure was made by Jeffrey S. Farrow in Tarsus Pharmaceuticals Inc where a trade of 1,284 Common Stock done at an average price of $46.3 was reported to US exchanges on March 18, 2025.

Screeners based on Insider Trading and SAST parameters